The identification of OpiHi monocytes suggests a previously unrecognized mechanism whereby opioid signaling in specific immune subsets may amplify TNF-mediated inflammation, potentially explaining the clinical dichotomy between protective receptor agonism and detrimental long-term opioid use in IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.